Literature DB >> 6379180

Impaired HLA capping capacity of peripheral blood lymphocytes in Duchenne muscular dystrophy.

A Sensi, A Venturoli, S Traniello, M Lucci, C Vullo, C Conighi, P L Mattiuz, O R Båricordi.   

Abstract

The cap capacity in nine Duchenne muscular dystrophy (DMD) patients and in 23 healthy male subjects (14 adults and nine neonates) has been investigated by inducing capping of HLA molecules. The evaluation of capping percentages ranged in healthy controls from 44 to 61 with a mean value of 53.39 +/- 4.89, while DMD patients displayed cap capacity of percentages varying from 15 to 38 with a mean value of 31.5 +/- 7.42. Statistical significance of the differences between the two groups, assessed by the Mann-Whitney U test, was p less than 0.00003. A correlation was found in DMD patients between cap capacity and age (tau = +0.657, p = 0.012). The results confirm previous reports of Ig capping impairment noted in B cells of the whole lymphocyte population, supporting the hypothesis of a systemic cellular defect in DMD patients. The data obtained suggest that HLA capping could overcome some of the technical difficulties of Ig capping and could be used as a diagnostic aid in antenatal detection of DMD.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6379180      PMCID: PMC1049262          DOI: 10.1136/jmg.21.3.182

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  16 in total

1.  Diminished cap formation in lymphocytes from patients and carriers of Duchenne muscular dystrophy.

Authors:  H L Verrill; N A Pickard; H D Gruemer
Journal:  Clin Chem       Date:  1977-12       Impact factor: 8.327

2.  Capping and the lymphocyte: models for membrane reorganization.

Authors:  G F Schreiner; E R Unanue
Journal:  J Immunol       Date:  1977-11       Impact factor: 5.422

3.  Antibody-induced redistribution of HL-A antigens at the cell surface.

Authors:  F M Kourilsky; D Silvestre; C Neauport-Sautes; Y Loosfelt; J Dausset
Journal:  Eur J Immunol       Date:  1972-06       Impact factor: 5.532

4.  An improved procedure for serum creatine phosphokinase determination.

Authors:  S B Rosalki
Journal:  J Lab Clin Med       Date:  1967-04

5.  Mechanisms of cellular enzyme release. I. Alteration in membrane fluidity and permeability.

Authors:  H L Verrill; N A Pickard; H D Gruemer
Journal:  Clin Chem       Date:  1977-12       Impact factor: 8.327

6.  Systemic membrane defect in the proximal muscular dystrophies.

Authors:  N A Pickard; H D Gruemer; H L Verrill; E R Isaacs; M Robinow; W E Nance; E C Myers; B Goldsmith
Journal:  N Engl J Med       Date:  1978-10-19       Impact factor: 91.245

7.  Lymphocyte capping in Duchenne muscular dystrophy.

Authors:  C M Stern; M C Kahan; V Dubowitz
Journal:  Lancet       Date:  1979-06-16       Impact factor: 79.321

Review 8.  Membrane and cytoplasmic changes in B lymphocytes induced by ligand-surface immunoglobulin interaction.

Authors:  G F Schreiner; E R Unanue
Journal:  Adv Immunol       Date:  1976       Impact factor: 3.543

9.  Lymphocyte capping: a diagnostic method in progressive muscular dystrophy?

Authors:  H J Nordal; T R Andersson; P Dietrichson
Journal:  Acta Neurol Scand       Date:  1982-05       Impact factor: 3.209

10.  Measurement of erythrocyte membrane elasticity as a diagnostic aid in Duchenne muscular dystrophy.

Authors:  G B Nash; S J Wyard
Journal:  J Med Genet       Date:  1982-08       Impact factor: 6.318

View more
  1 in total

1.  Impairment of capping in lymphoblastoid cell lines of Duchenne patients indicates an intrinsic cellular defect.

Authors:  O R Baricordi; A Sensi; A Balboni; G Romeo; M Rocchi; L Melchiorri; E Gandini
Journal:  Hum Genet       Date:  1989-10       Impact factor: 4.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.